Fibnib 150mg Soft Gelatin Capsule Substitute
by AYUR
by Others
by AYUR
by AYUR
by AYUR
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
NINTEDANIB-150MG
Uses:
Idiopathic pulmonary fibrosis
Medicinal Benefits:
Fibnib 150mg Soft Gelatin Capsule is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults. Fibnib 150mg Soft Gelatin Capsule can help effectively slow the rate of lung function decline by 50%. Fibnib 150mg Soft Gelatin Capsule helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Fibnib 150mg Soft Gelatin Capsule helps in slowing down the progress of idiopathic pulmonary fibrosis.
Fibnib 150mg Soft Gelatin Capsule helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, thereby helps you breathe better.
Avoid smoking before starting the treatment while taking Fibnib 150mg Soft Gelatin Capsule as smoking might alter the effectiveness of Fibnib 150mg Soft Gelatin Capsule.
Fibnib 150mg Soft Gelatin Capsule should be stopped when a person faces a serious side effect that affects life quality. Otherwise, it would be best to keep taking Fibnib 150mg Soft Gelatin Capsule until your doctor asks you to stop it.
If you have any surgery, including dental surgery, please inform your doctor if you are taking Fibnib 150mg Soft Gelatin Capsule as your doctor might stop Fibnib 150mg Soft Gelatin Capsule before undergoing surgery.
In elderly patients, the risk of side effects is more if you are taking Fibnib 150mg Soft Gelatin Capsule. For the patients who are elderly, dose adjustment might be required, or your doctor might prescribe any other medication safe for the elderly.
Idiopathic pulmonary fibrosis is treated with Fibnib 150mg Soft Gelatin Capsule (IPF; scarring of the lungs with an unknown cause). It's also used to treat fibrosing interstitial lung disorders.